Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AMGN | VRTX | REGN | BMY |
| Company | Orphazyme A/S ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9060 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 0.9571 | 279.84 | 406.95 | 913.21 | 44.47 |
| Low | 0.8457 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 0.8700 | 277.37 | 402.14 | 903.48 | 44.21 |
| Change | -0.0200 | +3.43 | +9.33 | +12.82 | +0.27 |
| % Change | -2.25% | +1.25% | +2.38% | +1.44% | +0.61% |
| Volume | 941,400 | 2,323,600 | 1,256,200 | 594,900 | 13,247,100 |
| 20-Day Average Volume | 1,980,090 | 2,243,020 | 999,485 | 476,575 | 14,065,495 |
| Previous Close | 0.8900 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 269.69 | 398.90 | 909.13 | 48.21 |
| 20-Day Raw Stochastic | 41.76% | 87.11% | 51.46% | 32.49% | 5.75% |
| 20-Day Relative Strength | 36.52% | 52.79% | 47.81% | 42.63% | 28.67% |
| Weighted Alpha | -87.89 | +14.56 | +14.78 | +17.16 | -36.23 |
| Today's Opinion | 100% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +1.60% since 04/24/24 | +0.34% since 04/24/24 | -0.34% since 04/24/24 | -9.52% since 04/24/24 |
| Low | 0.8275 on 03/29/22 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.9600 on 03/29/22 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -2.00% since 04/01/24 | -4.36% since 04/01/24 | -6.79% since 04/01/24 | -16.57% since 04/01/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 1.3720 on 03/10/22 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -14.54% since 02/01/24 | -7.31% since 02/01/24 | -5.67% since 02/01/24 | -9.16% since 02/01/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 2.7500 on 01/03/22 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +6.34% since 11/01/23 | +8.88% since 11/01/23 | +14.18% since 11/01/23 | -13.79% since 11/01/23 |
| Low | 0.5101 on 03/14/22 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 5.4900 on 10/13/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 35,312 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -97,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.68 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/05/22 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |